{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/tiredness-fatigue-in-adults/diagnosis/investigations/","result":{"pageContext":{"chapter":{"id":"118b8d1b-eabf-5783-b6d9-bf741008d8c3","slug":"investigations","fullItemName":"Investigations","depth":2,"htmlHeader":"<!-- begin field 9919407f-ec79-4f22-b0ef-86a70fd3ddfa --><h2>What investigations should I consider?</h2><!-- end field 9919407f-ec79-4f22-b0ef-86a70fd3ddfa -->","summary":"","htmlStringContent":"<!-- begin item c9545b38-3ee7-4f65-bc3d-32db8b1733ad --><!-- begin field 1369cf25-4a3a-4d61-b824-9f444537214b --><p><strong>Assess whether investigations are needed to identify an underlying cause for fatigue, based on the presenting <a class=\"topic-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/diagnosis/assessment/\">clinical features</a>.</strong></p><ul><li><strong>If an underlying physical cause is not obvious:</strong><ul><li><strong>Arrange the following first-line investigations, particularly if tiredness/fatigue has persisted for 1 month or longer:</strong><ul><li>Full blood count — to assess for anaemia, polycythaemia, haematological malignancy. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/anaemia-b12-folate-deficiency/\">Anaemia - B12 and folate deficiency</a>, <a class=\"topic-reference external-reference\" href=\"/topics/anaemia-iron-deficiency/\">Anaemia - iron deficiency</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/haematological-cancers-recognition-referral/\">Haematological cancers - recognition and referral</a> for more information.</li><li>Erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP) — may be raised in infection, inflammation, autoimmunity, and rarely solid organ neoplasms and possible lymphoproliferation.</li><li>Liver function tests — to assess for underlying liver disease. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/jaundice-in-adults/\">Jaundice in adults</a> for more information.</li><li>Renal function tests — to assess for underlying kidney disease and/or electrolyte imbalance. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/chronic-kidney-disease/\">Chronic kidney disease</a> for more information.</li><li>Thyroid function tests — to assess for possible hypo- or hyperthyroidism. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/hypothyroidism/\">Hypothyroidism</a> and <a class=\"topic-reference external-reference\" href=\"/topics/hyperthyroidism/\">Hyperthyroidism</a> for more information.</li><li>HbA1c — to assess for possible type 1 or type 2 diabetes mellitus. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/diabetes-type-1/\">Diabetes - type 1</a> and <a class=\"topic-reference external-reference\" href=\"/topics/diabetes-type-2/\">Diabetes - type 2</a> for more information.</li><li>IgA tissue transglutaminase — to assess for coeliac disease, which can present without bowel symptoms. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/coeliac-disease/\">Coeliac disease</a> for more information.</li></ul></li><li><strong>Consider arranging additional investigations on a case-by-case basis:</strong><ul><li>Bone biochemistry and myeloma screen — particularly if the person is 60 years of age or older. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/hypercalcaemia/\">Hypercalcaemia</a> and <a class=\"topic-reference external-reference\" href=\"/topics/multiple-myeloma/\">Multiple myeloma</a> for more information.</li><li>Vitamin D level — if the person is at risk of deficiency. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/vitamin-d-deficiency-in-adults-treatment-prevention/\">Vitamin D deficiency in adults - treatment and prevention</a> for more information.</li><li>Monospot test for infectious mononucleosis — in people younger than 40 years of age. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/glandular-fever-infectious-mononucleosis/\">Glandular fever (infectious mononucleosis)</a> for more information.</li><li>HIV test — if the person is at risk. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/hiv-infection-aids/\">HIV infection and AIDS</a> for more information.</li><li>Hepatitis serology — if the person is at risk. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/hepatitis-b/\">Hepatitis B</a> and <a class=\"topic-reference external-reference\" href=\"/topics/hepatitis-c/\">Hepatitis C</a> for more information.</li><li>Chest X-ray and sputum samples to screen for tuberculosis — if the person is at risk. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/tuberculosis/\">Tuberculosis</a> for more information.</li></ul></li></ul></li><li><strong>If tiredness/fatigue has persisted for 3 months or longer, consider the additional investigations above <em>and</em>:</strong><ul><li><strong>Arrange the following second-line investigations:</strong><ul><li>Urinalysis for protein and blood — to assess for renal tract infection, inflammation, or more rarely tumours.</li><li>Creatine kinase — if muscle tenderness or weakness, to assess for a neuromuscular cause.</li></ul></li><li><strong>Consider testing for the following, if there are suggestive clinical features:</strong><ul><li>Borreliosis (Lyme disease) — if a history of possible exposure to tick bites. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/lyme-disease/\">Lyme disease</a> for more information.</li><li>Other latent infections, such as toxoplasmosis, Epstein-Barr virus, and cytomegalovirus.</li></ul></li></ul></li><li><strong>Be aware that there is no specific diagnostic test for chronic fatigue syndrome (CFS).</strong></li></ul><!-- end field 1369cf25-4a3a-4d61-b824-9f444537214b --><!-- end item c9545b38-3ee7-4f65-bc3d-32db8b1733ad -->","topic":{"id":"61f35df8-36d2-541e-b997-0b78bad96289","topicId":"21fb5f0f-1e06-43c8-990f-bcded8cfc676","topicName":"Tiredness/fatigue in adults","slug":"tiredness-fatigue-in-adults","lastRevised":"Last revised in March 2020","chapters":[{"id":"404cb5e0-c0b1-516d-b548-9486e82f51b3","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"defb4b1a-b1c0-5607-98c7-67099c37b768","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"630ed210-1441-537d-a2e4-80c614c19753","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"4af39332-0dc0-5737-9443-75ab1ccb7e46","slug":"changes","fullItemName":"Changes"},{"id":"499e2dc9-675d-5c9c-8e90-33be13310544","slug":"update","fullItemName":"Update"}]},{"id":"6d9550cf-4496-5399-9386-2221acab329e","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"124b7023-365f-54a7-a251-a963db2de643","slug":"goals","fullItemName":"Goals"},{"id":"fdfc586d-81b1-5d44-a036-a438634061a5","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"56625d11-efe9-5e3f-b417-bc52a5fd8647","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"709f0c15-0a45-522f-ad1f-264575775c32","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"bbcffc23-5ef8-55a0-a824-0e0d22076edb","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"7fe1e226-6357-5456-a7f9-c486054d1473","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"be53ee8c-6122-5698-a5a7-1faf3f498cff","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"da4f6bbb-2c1d-53cd-975d-e679b502e8c9","slug":"definition","fullItemName":"Definition"},{"id":"add551e4-2d3b-5eca-b185-62b80e4e7446","slug":"causes","fullItemName":"Causes"},{"id":"127b3983-553b-546e-8f62-ab5da77e7988","slug":"prevalence","fullItemName":"Prevalence"},{"id":"46e6e501-33ea-5972-a2db-78fa9832e8bb","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"c3ac446e-5c06-55ac-85b8-487c1c11574c","slug":"complications","fullItemName":"Complications"},{"id":"158c640f-faae-5124-bb17-fc5f80bbcd02","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"2793dae3-1f43-5720-8d6a-024765f1a4fb","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"60b0af18-e161-532f-80e9-d126e6b8fdfe","slug":"assessment","fullItemName":"Assessment"},{"id":"adeaf5f9-6f69-5d16-a417-6c3e96ba3b0d","slug":"diagnosis-of-cfs","fullItemName":"Diagnosis of CFS"},{"id":"118b8d1b-eabf-5783-b6d9-bf741008d8c3","slug":"investigations","fullItemName":"Investigations"}]},{"id":"d20f8dd6-6b85-52a1-b3f0-991e89e6578d","fullItemName":"Management","slug":"management","subChapters":[{"id":"d03a188b-cced-5325-b1c4-2a0b5f3d6156","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"fb121999-e011-54b3-ba46-e7254fe5cec3","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"c497ff8c-06b6-56cf-aec2-5b3475c6443d","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"0107b9bc-4dbd-5c8b-98e6-2842cdf41aab","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"add2e0e1-eaf4-5755-b758-3448de68adf6","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"5b2c98da-05b4-5b25-badd-33cffca97860","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"72de0853-60a0-5de2-a56b-e42ac2e4695a","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"ae0893a4-a9bc-5015-86dd-03f492054e0d","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"4bad5822-74de-5e27-90d9-3ef238914249","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"2793dae3-1f43-5720-8d6a-024765f1a4fb","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"340dee7d-7809-5d2b-81b1-dd71b67d8f69","slug":"basis-for-recommendation-857","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 3cb89410-5bd2-409c-b773-92b548b8474a --><h3>Basis for recommendation</h3><!-- end field 3cb89410-5bd2-409c-b773-92b548b8474a -->","summary":null,"htmlStringContent":"<!-- begin item 85730c02-722a-4440-964e-c34eb4c56947 --><!-- begin field f10f943d-f7a5-4463-891e-6c847aec5b3a --><p>The recommendations on investigation of tiredness/fatigue are based on the National Institute for Health and Care Excellence (NICE) clinical guideline <em>Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): diagnosis and management of CFS/ME in adults and children </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">NICE, 2007</a>], the Canadian Toward Optimized Practice (TOP) summary <em>Identification and symptom management of myalgic encephalomyelitis/chronic fatigue syndrome</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">TOP, 2016</a>], a UK cohort study of the prevalence and symptom burden of chronic fatigue syndrome [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">Strassheim, 2018</a>], a cohort study of the incidence of chronic fatigue syndrome [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">Collin, 2017</a>], a cluster study of the value of blood tests for unexplained fatigue [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">Koch, 2009</a>], and expert opinion in review articles on tiredness [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">Stadje, 2016</a>], on investigating unexplained fatigue [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">Bansal, 2016</a>], and on chronic fatigue syndrome (CFS) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">Fukuda, 1994</a>].</p><h4>Arranging first-line investigations</h4><ul><li>Expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">Fukuda, 1994</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">Bansal, 2016</a>] and a cohort study of the incidence of CFS [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">Collin, 2017</a>], state the aim of investigations is to rule out alternative diagnoses to CFS and identify specific comorbidities.</li><li>A systematic review of 26 studies investigating the differential diagnosis of tiredness in primary care found that depression was the most common cause (seen in 18.5% of people), with other causes such as anaemia (2.8%) and malignancy (0.6%) being less common. A diagnosis of CFS was identified in 2% of cases [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">Stadje, 2016</a>].<ul><li>The review noted that serious underlying disease was rare, and investigations for fatigue are indicated depending on the specific findings on history and examination.</li><li>It states that excessive diagnostic testing will lead to considerable false-positive results that rarely help to detect serious underlying disease if fatigue occurs as an isolated symptom.</li></ul></li><li>The recommendation on the specific first-line blood tests to arrange and their rationale is based on the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">NICE, 2007</a>] and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">Fukuda, 1994</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">Bansal, 2016</a>]. It is also supported by the expert opinion of previous external reviewers of this CKS topic.</li><li>A Dutch single cluster randomized trial (n = 325) that compared the diagnostic yield of a limited set of blood tests compared with an 'expanded set' in people presenting with unexplained fatigue in primary care, found the limited set (including full blood count, inflammatory markers, glucose, and thyroid-stimulating hormone) was almost as useful diagnostically as the expanded set, which had an increased risk of false-positive results. It also found that delaying blood tests for 4 weeks from initial presentation does not appear to miss serious diagnoses. Conclusions were, however, limited by the study methodology [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">Koch, 2009</a>].</li></ul><h4>Considering additional investigations on a case-by-case basis</h4><ul><li>The recommendation on additional blood tests to consider, such as bone biochemistry, are largely based on the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">NICE, 2007</a>]. This is supported by expert opinion in a review article that recommends arranging a myeloma screen for investigation of unexplained fatigue [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">Bansal, 2016</a>].</li><li>The recommendation to check serum vitamin D is based on a single observational study (n = 174 adults) that showed a high prevalence (77.2%) of vitamin D deficiency in people presenting with fatigue lasting longer than 1 month as a primary complaint. Following normalization of vitamin D levels via supplementation, a significant reduction in fatigue scores was observed [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">Roy, 2014</a>]. This recommendation is supported by the expert opinion of previous external reviewers of this CKS topic.</li><li>The recommendation to test for infectious mononucleosis in people younger than 40 years of age is extrapolated from the NICE clinical guideline, which recommends testing if the history is indicative [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">NICE, 2007</a>]. This acute infection is a relatively common cause of tiredness, and may be detected in people who are otherwise asymptomatic [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">Koch, 2009</a>].</li><li>The recommendation to test for HIV and hepatitis if there are suggestive clinical features is based on the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">NICE, 2007</a>] and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">Fukuda, 1994</a>].</li></ul><h4>Arranging second-line investigations</h4><ul><li>The recommendations on arranging a urine dip and creatine kinase blood test are based on the NICE clinical guideline, which recommends these tests if symptoms have persisted and a diagnosis of CFS is suspected [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">NICE, 2007</a>]. This approach is supported by expert opinion in a review article that suggests that serum creatine kinase is helpful, presumably to rule out an underlying neuromuscular cause for symptoms [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">Bansal, 2016</a>]. The recommendation to consider these tests if fatigue persists for 3 months is pragmatic, based on what CKS considers to be good clinical practice.</li><li>The recommendation to consider testing for Lyme disease and other latent infections if there are suggestive clinical features is based on the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">NICE, 2007</a>]. The recommendation on testing for Lyme disease is also supported by expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">Bansal, 2016</a>].</li></ul><h4>No diagnostic test for CFS</h4><ul><li>The information that there is no diagnostic test for identifying CFS is based on the NICE clinical guideline, which notes that CFS is diagnosed on clinical grounds alone [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">NICE, 2007</a>].</li><li>This approach is supported by the TOP summary [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">TOP, 2016</a>], a UK cohort study [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">Strassheim, 2018</a>], and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">Fukuda, 1994</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/tiredness-fatigue-in-adults/references/\">Bansal, 2016</a>].</li></ul><!-- end field f10f943d-f7a5-4463-891e-6c847aec5b3a --><!-- end item 85730c02-722a-4440-964e-c34eb4c56947 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}